ConvaTec
About ConvaTec
ConvaTec is a UK-headquartered global medical-products group specialising in advanced wound care, ostomy, continence and infusion care.
Milestones
Milestones as listed on convatecgroup.com, checked 26 Sep 2026. Details can change; the linked page is the authoritative source.
Leadership Team
Leadership as listed on convatecgroup.com, checked 26 Sep 2026. Details can change; the linked page is the authoritative source.
Products & Services
Products and services as listed on convatecgroup.com, checked 26 Sep 2026. Details can change; the linked page is the authoritative source.
Advanced Wound Care
Products for managing chronic and complex wounds.
Source: convatecgroup.comContinence Care
Products and home services for continence management.
Source: convatecgroup.comInfusion Care
Infusion sets and technologies used for drug delivery such as insulin pumps.
Source: convatecgroup.comStomahesive skin barrier
The company's first product, a hydrocolloid skin barrier launched after its 1978 founding.
Source: convatecgroup.comPipeline & Regulatory Record
What public registers list for ConvaTec: clinical trials it sponsors, FDA device clearances, Irish licences, recent approvals and supply shortages. Rebuilt daily, last on 10 Oct 2026.
Clinical trials 6 in our ClinicalTrials.gov registers
| Study | Phase | Status |
|---|---|---|
| Observational Study to Investigate the Use of Sterilized Porcine Placental Tissue in the Treatment of Chronic VLU NCT06400875 · Ulcer Venous, Wound Heal |
Observational | Active, closed |
| Sterilised, Porcine Placental Tissue in the Treatment of Chronic Diabetic Foot Ulcers NCT05687656 · Diabetic Foot Ulcer |
Not applicable | Active, closed |
| ConvaVAC™ Ag+ Negative Pressure Wound Therapy System in Chronic Wounds NCT07342049 · Venous Leg Ulcer (VLU) |
Not applicable | Recruiting |
| EDX110 Randomized Control Trial for Treatment of DFUs NCT07209358 · Wound Heal, Diabetic Foot Ulcer |
Not applicable | Recruiting |
| IDEAL: Efficacy of Porcine Placental Extracellular Matrix Augmented Plus Standard of Care (SOC) Versus SOC Alone for the Management of Diabetic Foot Ulcers NCT06616844 · Wound Heal, Ulcer |
Not applicable | Recruiting |
| INNOVEN: Efficacy of Porcine Placental Extracellular Matrix Plus Standard of Care (SOC) Versus SOC Alone NCT06606210 · Wound Heal, Venous Leg Ulcer |
Not applicable | Recruiting |
All trials by sponsor name 1 registry name
FDA 510(k) device clearances 1
- Cure Aqua™ Ready to Use Hydrophilic Intermittent Catheter Female (CH06 - CH16); Cure Aqua™ Ready to Use Hydrophilic Intermittent Catheter Male Straight (CH06 -…K260737 · Convatec · 5 Aug 2026 · Class 2
Clearances in our FDA device register: every clearance to an Irish-based applicant, plus the last 90 days worldwide.
Group (ConvaTec): founded 1978, headquarters Reading, website convatec.com. Wikidata Q5166105 · Wikipedia. From Wikidata (CC0), matched by the group's Legal Entity Identifier.
How this is matched: register records are linked to this page by the organisation name they carry, here ConvaTec Inc.; Convatec. Spot a wrong match? Tell us.
Financials & Irish Entities
Convatec Group plc does not file annual reports with the US SEC, so we do not show its financial statements here.
Companies registered in Ireland 1 active in the CRO register
| Company | CRO no. | Registered | Last accounts |
|---|---|---|---|
| Convatec Healthcare Ireland Limited LTD - Private Company Limited by Shares | 457834 | 2008 | Dec 2024 |
From the Companies Registration Office (CRO Open Data, CC BY 4.0). A company is listed when GLEIF's legal entity register links it to Convatec Group plc as its ultimate parent, or when we checked its name and registered address by hand. Branches of foreign companies appear as "External company". Spot a missing or wrong entry? Tell us.